No overt GvHD was observed in the high TNB-738 group, but human T cells did express the activation marker CD69 (12% of spleen and 26% of bone marrow CD4+cells and 25% of spleen and 48% of bone marrow CD8+ cells - Supplementary Figure 1B). The gene discussed is CD69; the disease is graft versus host disease.